IBB vs IHI: holdings overlap, shared companies and scores

As of September 11, 2026, IBB and IHI overlap 0.3% by weight. iShares Biotechnology ETF (IBB): U.S. biotechnology stocks. iShares U.S. Medical Devices ETF (IHI): U.S. medical equipment manufacturers.

Updated September 11, 2026

How much do IBB and IHI overlap?

As of September 11, 2026, IBB and IHI overlap 0.3% by weight.

0% of IBB is already inside IHI.

0% of IHI is already inside IBB.

IBB holds 239 companies and IHI holds 49; 3 are in both.

Computed by ETF Copilot from both funds' holdings rather than quoted from a data provider, and rebuilt nightly.

How does ETF Copilot score IBB and IHI?

As of September 11, 2026, ETF Copilot scores IBB 3.1 out of 10 and IHI 4.9 out of 10.

They differ most on Valuation: IBB 3.5 and IHI 9.8.

The five factor scores behind them are set out below, 0–10 and higher is better, ranked against every US equity ETF we track.

IBB vs IHI — ETF Copilot factor scores, 0–10
FactorIBBIHI
Growth1.96.9
Valuation3.59.8
Risk4.24.4
Quality3.42.9
Return3.11.2

IHI is the cheaper of the two at 0.37% a year

As of September 11, 2026, IBB charges 0.44% a year, yields 0.46% and holds $10.7B in assets across 239 positions.

As of September 11, 2026, IHI charges 0.37% a year, yields 1.00% and holds $3.4B in assets across 49 positions.

IBB vs IHI — cost, income and size
MeasureIBBIHI
Expense ratio0.44%0.37%
Dividend yield0.46%1.00%
Assets under management$10.7B$3.4B
Holdings23949

Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.

Where IBB and IHI trade against their own history

IBB trades at 22.7 times earnings, against its own median of 21.5, and is more expensive than 60% of its own 114 monthly readings since 2017.

IHI trades at 30.0 times earnings, against its own median of 35.0, and is cheaper than 88% of its own 114 monthly readings since 2017.

What moved IBB and IHI this week

IBB fell 5.1% in the week to September 11, 2026. The holdings that moved it most were Amgen (−15.0%), Vertex Pharmaceuticals (−7.6%) and Regeneron Pharmaceuticals (−7.3%); Roivant Sciences (+18.6%) pushed the other way.

IHI fell 5.6% in the week to September 11, 2026. The holdings that moved it most were Abbott Laboratories (−6.3%), Stryker (−10.5%) and Dexcom (−7.4%); Inspire Medical Systems (+17.5%) pushed the other way.

What do IBB and IHI each hold?

What's inside IBB: AI 1%.

48% of IBB is its ten largest holdings.

75% of IHI is its ten largest holdings.

Compare with similar funds

Cite this

ETF Copilot, “IBB vs IHI holdings overlap and scores”, as of September 11, 2026.
https://etf-copilot.com/compare/ibb-vs-ihi

  1. iShares Biotechnology ETF (IBB)
  2. iShares U.S. Medical Devices ETF (IHI)

Register free to unlock IBB vs IHI prices and holdings on ETF Copilot.

Register free →